The Athlete Biological Passport: a ‘magic bullet’ for EPO detection? Part 2 of 2
Athlete Biological Passport Procedure Published 07 February 2013 By: Emma Mason
The anti-doping community has taken note of these criticisms (see part 1) and in 2000 WADA approved its operating guidelines for the Athlete Biological Passport (ABP) marking a return to indirect testing methods and a change of analytical focus from urine to blood.
Get access to this article and all of the expert analysis and commentary at LawInSport
Already a member?
Articles, webinars, conference videos and podcast transcripts
This work was written for and first published on LawInSport.com (unless otherwise stated) and the copyright is owned by LawInSport Ltd. Permission is granted to make digital or hard copies of this work (or part, or abstracts, of it) for personal use provided copies are not made or distributed for profit or commercial advantage, and provided that all copies bear this notice and full citation on the first page (which should include the URL, company name (LawInSport), article title, author name, date of the publication and date of use) of any copies made. Copyright for components of this work owned by parties other than LawInSport must be honoured.
- Tags: Anti-Doping | Athlete Biological Passport (ABP) | Court of Arbitration for Sport (CAS) | Erythropoietin | UCI | US Anti-Doping Agency (USADA) | World Anti-Doping Agency (WADA)
Emma is a trainee solicitor in Squire Patton Boggs’ sports litigation department who has completed seats in corporate, international dispute resolution and a secondment to Chelsea Football Club. During her traineeship Emma has, from a sporting perspective, assisted with the sale of a Championship football club and the provision of advice to various International Federations and Premier League football clubs.